SCHEMBL16638077

SCHEMBL16638077

NCCc1ccc2c(c1)Cc1ccccc1-2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.59
ALDH1A1 P00352 2/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
KDM4E B2RXH2 1/20 0.59
LMNA P02545 1/20 0.59
MAPT P10636 1/20 0.59
HPGD P15428 1/20 0.59
TSHR P16473 2/20 0.53
ATM Q13315 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TP53 P04637 1/20 0.51
MAPK1 P28482 1/20 0.51
GPR84 Q9NQS5 1/20 0.51
CYP17A1 P05093 1/20 0.49
SRD5A2 P31213 1/20 0.45
HTT P42858 1/20 0.45
BACE1 P56817 1/20 0.44
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195015 0.89 GPR84 (0.60) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL8971829 0.88 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL28946733 0.85 ALDH1A1 (0.58) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL1609629 0.82 TSHR (0.53) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL3453144 0.82 TSHR (0.53) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL18584142 0.82 GPR84 (0.55) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL2312811 0.82 GPR84 (0.55) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL7190397 0.81 GPR84 (0.52) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL598903 0.81 TSHR (0.58) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL29566807 0.79 TSHR (0.54) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055313-A1 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2016-08-17 EP disclosed
WO-2015052065-A1 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-04-16 WO disclosed